Treatment of allergic rhinitis with intranasal glucocorticosteroids
Kryukov A.I., Kunelskaya N.L., Tsarapkin G.Yu., Tovmasyan A.S.
Scientific Research Clinical Institute of Otorhinolaryngology named after L.I. Sverzhevsky, Moscow
Over the past decades, there has been a steady increase in allergic diseases of the upper respiratory tract. In terms of prevalence, and the influence on the health and quality of life of patients allergic rhinitis (AR) occupies a leading place in the structure of allergopathology, its specific gravity reaches 60-70%. AR is one of the most common diseases, its prevalence and frequency continues to grow at a rather high rate. According to the results of epidemiological studies, more than 20% of the population of all age groups suffer from AR. Treatment of AR patients includes non-pharmacological and pharmacological methods. All drugs used to treat AR can be divided into 2 groups: 1) drugs that control the symptoms of the disease, and 2) drugs that have a truly therapeutic effect. The last group includes, primarily, intranasal glucocorticosteroids (InGCS). Experimental and clinical studies show that glucocorticoids affect practically all stages of pathogenesis of AR. Their therapeutic effect in AR is primarily associated with anti-inflammatory and desensitizing effects. The article describes the experience and application of InGCS budesonide with the trade name Tafen® nasal in the treatment of AR.
Key words: allergic rhinitis, allergen, intranasal glucocorticosteroids, budesonide, Tafen nasal.
For citation: Kryukov A.I., Kunelskaya N.L., Tsarapkin G.Yu., Tovmasyan A.S. Treatment of allergic rhinitis with intranasal glucocorticosteroids // RMJ. Medical Review. 2018. № 1(I). P. 4–6.
References
1. Кудайбергенова С.Ф. Информативность цитологического метода исследования при аллергическом рините с сопутствующей патологией со стороны ЛОР-органов // Вестник оториноларингологии. 2010. № 3. С. 37–38 [Kudaybergenova S.F. Informativnost’ tsitologicheskogo metoda issledovaniya pri allergicheskom rinite s soputstvuyushchey patologiyey so storony LOR-organov // Vestnik otorinolaringologii. 2010. № 3. S. 37–38 (in Russian)].
2. Лопатин А.С. Ринит: руководство для врачей. М.: Литтерра, 2010. 424 с. [Lopatin A.S. Rinit: rukovodstvo dlya vrachey. M.: Litterra, 2010. 424 s. (in Russian)].
3. Лопатин А.С., Латышева Е.Н. Левоцетиризин в терапии аллергического ринита // Вестник оториноларингологии. 2010. № 4. С. 98–101 [Lopatin A.S., Latysheva Ye.N. Levotsetirizin v terapii allergicheskogo rinita // Vestnik otorinolaringologii. 2010. № 4. S. 98–101 (in Russian)].
4. Горячкина Л.А., Передкова Е.В., Бжедугова Е.Р. Лечение поллинозов // Лечащий врач. 2004. № 3. С. 1–6 [Goryachkina L.A., Peredkova Ye.V., Bzhedugova Ye.R. Lecheniye pollinozov // Lechashchiy vrach. 2004. № 3. S. 1–6 (in Russian)].
5. Гусева Е.Д., Файзуллина Р.М. Особенности мукозального иммунитета у детей с аллергическим ринитом // Вестник оториноларингологии. 2012. № 6. С. 33–35 [Guseva Ye.D., Fayzullina R.M. Osobennosti mukozal’nogo immuniteta u detey s allergicheskim rinitom // Vestnik otorinolaringologii. 2012. № 6. S. 33–35 (in Russian)].
6. Ильина Н.И., Феденко Е.С., Курбачева О.М. Аллергический ринит. Пособие для врачей общей практики и фармацевтов // Российский аллергологический журнал. 2004. № 3. С. 12–13 [Il’ina N.I., Fedenko Ye.S., Kurbacheva O.M. Allergicheskiy rinit. Posobiye dlya vrachey obshchey praktiki i farmatsevtov // Rossiyskiy allergologicheskiy zhurnal. 2004. № 3. S. 12–13 (in Russian)].
7. Зайцева О.В. Подходы к диагностике и лечению аллергического ринита // Вестник оториноларингологии. 2011. № 5. С. 62–65 [Zaytseva O.V. Podkhody k diagnostike i lecheniyu allergicheskogo rinita // Vestnik otorinolaringologii. 2011. № 5. S. 62–65 (in Russian)].
8. Jeffery P.K., Godfrey R.W.A., Adelroth E. et al. Effects of treatment on airway inflammation and thickening of reticular collagen in asthma: a quantitative light and electron microscopic study // Am Rev Respir Dis. 1992. Vol. 145. Р. 890–899.
9. Коленчукова О.А., Игнатова И.А., Смирнова С.В. и др. Особенности микрофлоры слизистой оболочки носа у больных аллергическим риносинуситом // Вестник оториноларингологии. 2008. № 5. С. 33–35 [Kolenchukova O.A., Ignatova I.A., Smirnova S.V. i dr. Osobennosti mikroflory slizistoy obolochki nosa u bol’nykh allergicheskim rinosinusitom // Vestnik otorinolaringologii. 2008. № 5. S. 33–35 (in Russian)].
10. Zhou J., Liu D.-F., Liu C. et al. Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism // Allergy. 2008. Vol. 63 (9). Р. 1177–1185.
11. Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М.: Фармарус Принт, 1998. 252 с. [Gushchin I.S. Allergicheskoye vospaleniye i yego farmakologicheskiy kontrol’. M.: Farmarus Print, 1998. 252 s. (in Russian)].
12. Falt A., Bengtsson T., Kennedy B-M. et al. Exposure of infants to budesonide through breast milk of asthmatic mothers // J. Allergy Clin. Immunol. 2007. Vol. 120 (4). P. 798–802.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Previous article
Next article
